Consistency in the analysis and reporting of primary end points in oncology randomized controlled trials from registration to publication: A systematic review

Journal of Clinical Oncology

Volumn 30, Issue 2, 2012, Pages 210-216

  You, Benoit ^a,c,d,e   Gan, Hui K ^a,f   Pond, Gregory ^b   Chen, Eric X ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

^c CENTRE HOSPITALIER LYON SUD   (France)

^d UNIVERSITÉ LYON 1   (France)

^e UNIVERSITÉ DE LYON   (France)

^f AUSTIN HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER REGISTRY; CANCER RESEARCH; DATA ANALYSIS; DRUG INDUSTRY; FUNDING; HUMAN; MANDATORY REPORTING; MEDLINE; METHODOLOGY; PHASE 3 CLINICAL TRIAL (TOPIC); PRACTICE GUIDELINE; PRIORITY JOURNAL; PUBLICATION; QUALITY CONTROL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; SAMPLE SIZE; SOLID TUMOR; SYSTEMATIC REVIEW;

ENDPOINT DETERMINATION; HUMANS; MEDICAL ONCOLOGY; PUBLISHING; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84855595256     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.37.0890     Document Type: Review

References (29)

1. Ross JS, Mulvey GK, Hines EM, et al: Trial publication after registration in ClinicalTrials.Gov: A cross-sectional analysis. PLoS Med 6:e1000144, 2009
2. Rasmussen N, Lee K, Bero L: Association of trial registration with the results and conclusions of published trials of new oncology drugs. Trials 10:116, 2009
3. De Angelis C, Drazen JM, Frizelle FA, et al: Clinical trial registration: A statement from the International Committee of Medical Journal Editors. N Engl J Med 351:1250-1251, 2004 (Pubitemid 39296312)
4. Zarin DA, Ide NC, Tse T, et al: Issues in the registration of clinical trials. JAMA 297:2112-2120, 2007 (Pubitemid 46798169)
5. Zarin DA, Tse T, Ide NC: Trial Registration at ClinicalTrials.gov between May and October 2005. N Engl J Med 353:2779-2787, 2005
6. De Angelis CD, Drazen JM, Frizelle FA, et al: Is this clinical trial fully registered? A statement from the International Committee of Medical Journal Editors. N Engl J Med 352:2436-2438, 2005 (Pubitemid 40958442)
7. Boutron I, Dutton S, Ravaud P, et al: Reporting and interpretation of randomized controlled trials with statistically nonsignificant results for primary outcomes. JAMA 303:2058-2064, 2010
8. Chan AW, Hróbjartsson A, Haahr MT, et al: Empirical evidence for selective reporting of outcomes in randomized trials: Comparison of protocols to published articles. JAMA 291:2457-2465, 2004 (Pubitemid 38669189)
9. Yank V, Rennie D, Bero LA: Financial ties and concordance between results and conclusions in meta-analyses: Retrospective cohort study. BMJ 335:1202-1205, 2007 (Pubitemid 350273305)
10. Kirkham JJ, Dwan KM, Altman DG, et al: The impact of outcome reporting bias in randomised controlled trials on a cohort of systematic reviews. BMJ 340:c365, 2010
11. Dwan K, Altman DG, Arnaiz JA, et al: Systematic review of the empirical evidence of study publication bias and outcome reporting bias. PLoS One 3:e3081, 2008
12. Mathieu S, Boutron I, Moher D, et al: Comparison of registered and published primary outcomes in randomized controlled trials. JAMA 302:977-984, 2009
13. ClinicalTrials.gov: Search. http://clinicaltrials.gov/ct2/search
14. BioMed Central: International Standard Randomised Controlled Trial Number Register. http:// www.controlled-trials.com/isrctn/
15. Moher D, Schulz KF, Altman DG: The CONSORT statement: Revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 357:1191-1194, 2001 (Pubitemid 32378696)
16. Piaggio G, Elbourne DR, Altman DG, et al: Reporting of noninferiority and equivalence randomized trials: An extension of the CONSORT statement. JAMA 295:1152-1160, 2006 (Pubitemid 43352345)
17. Krzyzanowska MK, Pintilie M, Tannock IF: Factors associated with failure to publish large randomized trials presented at an oncology meeting. JAMA 290:495-501, 2003 (Pubitemid 37430503)
18. Chan AW, Krleza-Jerić K, Schmid I, et al: Outcome reporting bias in randomized trials funded by the Canadian Institutes of Health Research. CMAJ 171:735-740, 2004 (Pubitemid 39319090)
19. Chan AW, Altman DG: Identifying outcome reporting bias in randomised trials on PubMed: Review of publications and survey of authors. BMJ 330:753, 2005
20. Greene WL, Concato J, Feinstein AR: Claims of equivalence in medical research: Are they supported by the evidence? Ann Intern Med 132:715-722, 2000 (Pubitemid 30244171)
21. Zee BC: Planned equivalence or noninferiority trials versus unplanned noninferiority claims: Are they equal? J Clin Oncol 24:1026-1028, 2006
22. Freidlin B, Korn EL, George SL, et al: Randomized clinical trial design for assessing noninferiority when superiority is expected. J Clin Oncol 25:5019-5023, 2007 (Pubitemid 350220436)
23. Balasubramanian SP, Wiener M, Alshameeri Z, et al: Standards of reporting of randomized controlled trials in general surgery: Can we do better? Ann Surg 244:663-667, 2006 (Pubitemid 44629937)
24. Mills EJ, Wu P, Gagnier J, et al: The quality of randomized trial reporting in leading medical journals since the revised CONSORT statement. Contemp Clin Trials 26:480-487, 2005 (Pubitemid 41073676)
25. Kane RL, Wang J, Garrard J: Reporting in randomized clinical trials improved after adoption of the CONSORT statement. J Clin Epidemiol 60:241-249, 2007 (Pubitemid 46210137)
26. Toulmonde M, Bellera C, Mathoulin-Pelissier S, et al: Quality of randomized controlled trials reporting in the treatment of sarcomas. J Clin Oncol 29:1204-1209, 2011
27. Horton R: The hidden research paper. JAMA 287:2775-2778, 2002
28. Moher D, Hopewell S, Schulz KF, et al: CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomised trials.BMJ340:c869, 2010
29. Haller DG, Cannistra SA: Providing protocol information for journal of clinical oncology readers: What practicing clinicians need to know. J Clin Oncol 29:1091, 2011